WHWK · Whitehawk Therapeutics, Inc.
$4.46
-0.22 (-4.70%)
At close · Aug 14
Market Cap
$254.26M
Shares
57.01M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.46
Open$4.68
Day$4.41–4.68
52W close$1.60–5.10
Avg vol 30d486K
Short int4.4M · 7.8% float · 10.4d
Short vol37%
Last earningsMar 18, 2025
DataAug 2021–Aug 2026
Filing10-Q · Aug 6
Raw chart and full-history price indicators begin at the captured split on Aug 27, 2021; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+30%
above
Price vs 50-day avg
+8%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
82%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+15%
trailing
6-month return
+49%
trailing
YTD return
+84%
this year
Relative strength
+35%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
+26% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
7.77% of float · ▲ +6.0% MoM · 10.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
78 holders — near 3-yr high, broad support
Squeeze score
69
elevated · 0–100
Fundamentals
Revenue growth
−73%
Y/Y
EPS growth
+86%
Y/Y
Free cash flow
$-98.0M
Balance sheet
$37.6M
net cash
Quant / Vol
risk profile
Volatility
79%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+30%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
82%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
+26% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
7.77% of float · ▲ +6.0% MoM · 10.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
78 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $4 · 82%
Range high $5
vs 200-day avg +30%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WHWK
this stock
Whitehawk Therapeutics, Inc.
|
$254.26M | +84.3% | -72.5% | — | 7.8% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Aug 27, 2021; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WHWK | -6.3% | +14.7% | +48.7% | +15.8% | +84.3% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -6.7% | +10.2% | +34.9% | +11.9% | +70.5% |
Key facts
CIK
1422142
CUSIP
00032Q104
13F (30d)
79 filings
78 filers
Visit website
Investor relations